September 29, 2020
Shuiying Hu, PhD, research assistant professor in the College of Pharmacy Division of Outcomes and Translational Sciences, recently received the Darrell Abernethy Early Stage Investigator Award by the American Society for Clinical Pharmacology and Therapeutics (ASCPT). The organization will recognize Dr. Hu during their 2021 Annual Meeting, March 8-17, 2021.
Dr. Hu will receive a $10,000 grant for a one-year period, Jan. 1 – Dec. 31, 2021. Per the criteria for receiving the award, she will submit her research for presentation at the ASCPT 2022 Annual Meeting, following the completion of the grant, and will submit a full research paper to one of ASCPT's three journals, Clinical Pharmacology & Therapeutics, CPT: Pharmacometrics & Systems Pharmacology or Clinical and Translational Science.
Dr. Hu’s research focuses primarily on drug development and translational cancer pharmacology. Her current projects are focused on the development of transport modulators that could be used in conjunction with neurotoxic chemotherapy. The overall goal of her research is to evaluate the role of solute carriers in cancer drug-induced toxicity profiles, in particular peripheral neuropathy. Additionally, she works to identify chemical inhibitors of critical transporters and explore novel strategies to ameliorate the incidence and severity of debilitating side effects of cancer drugs.